NO921451L - Heterocykliske amider - Google Patents
Heterocykliske amiderInfo
- Publication number
- NO921451L NO921451L NO92921451A NO921451A NO921451L NO 921451 L NO921451 L NO 921451L NO 92921451 A NO92921451 A NO 92921451A NO 921451 A NO921451 A NO 921451A NO 921451 L NO921451 L NO 921451L
- Authority
- NO
- Norway
- Prior art keywords
- aryl
- hydrogen
- formula
- heteroaryl
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919108357A GB9108357D0 (en) | 1991-04-18 | 1991-04-18 | Heterocyclic amides |
GB919108358A GB9108358D0 (en) | 1991-04-18 | 1991-04-18 | Heterocyclic compounds |
GB929205392A GB9205392D0 (en) | 1992-03-12 | 1992-03-12 | Heterocyclic amides |
Publications (2)
Publication Number | Publication Date |
---|---|
NO921451D0 NO921451D0 (no) | 1992-04-10 |
NO921451L true NO921451L (no) | 1992-10-19 |
Family
ID=27265602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92921451A NO921451L (no) | 1991-04-18 | 1992-04-10 | Heterocykliske amider |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0509769B1 (de) |
JP (1) | JPH0656785A (de) |
KR (1) | KR920019750A (de) |
AU (1) | AU660664B2 (de) |
CA (1) | CA2065794A1 (de) |
CS (1) | CS117692A3 (de) |
DE (1) | DE69213537T2 (de) |
FI (1) | FI921598A (de) |
GB (1) | GB9207145D0 (de) |
HU (1) | HUT66541A (de) |
IE (1) | IE921159A1 (de) |
IL (1) | IL101555A0 (de) |
NO (1) | NO921451L (de) |
NZ (1) | NZ242322A (de) |
TW (1) | TW262475B (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521179A (en) * | 1991-04-18 | 1996-05-28 | Zeneca Limited | Heterocyclic amides |
JPH07505877A (ja) * | 1992-04-16 | 1995-06-29 | ゼネカ・リミテッド | α−アミノボロン酸ペプチド及びエラスターゼ阻害剤としてのそれらの使用 |
EP0636144A1 (de) * | 1992-04-16 | 1995-02-01 | Zeneca Limited | Peptide mit einer alphaaminoborsaeuregruppe und ihre verwendung als elastasehemmer |
US5486529A (en) * | 1992-04-16 | 1996-01-23 | Zeneca Limited | Certain pyridyl ketones for treating diseases involving leukocyte elastase |
US5441960A (en) * | 1992-04-16 | 1995-08-15 | Zeneca Limited | 1-pyrimidinylacetamide human leukocyte elastate inhibitors |
GB9307555D0 (en) * | 1992-04-16 | 1993-06-02 | Zeneca Ltd | Heterocyclic compounds |
GB9211783D0 (en) * | 1992-06-04 | 1992-07-15 | Ici Plc | Amide derivatives |
GB9214053D0 (en) * | 1992-07-02 | 1992-08-12 | Ici Plc | Heterocyclic amides |
US6608204B1 (en) * | 1994-12-13 | 2003-08-19 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
US5658930A (en) * | 1994-12-13 | 1997-08-19 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
US5656645A (en) * | 1994-12-13 | 1997-08-12 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
US5948785A (en) * | 1995-04-27 | 1999-09-07 | The Green Cross Corporation | Heterocyclic amide compounds and pharmaceutical use of the same |
WO1997001338A1 (en) * | 1995-06-27 | 1997-01-16 | Merck & Co., Inc. | Pyridinone-thrombin inhibitors |
US5668289A (en) * | 1996-06-24 | 1997-09-16 | Merck & Co., Inc. | Pyridinone thrombin inhibitors |
US5872138A (en) * | 1996-09-13 | 1999-02-16 | Merck & Co., Inc. | Thrombin inhibitors |
US5869487A (en) * | 1996-10-24 | 1999-02-09 | Merck & Co., Inc. | Pyrido 3,4-B!pyrazines for use as thrombin inhibitors |
KR20000052775A (ko) * | 1996-10-25 | 2000-08-25 | 가마쿠라 아키오 | 신규한 헤테로사이클릭 아미드 화합물 및 의약으로서의 그의 용도 |
US6017934A (en) * | 1997-01-22 | 2000-01-25 | Merck & Co., Inc. | Thrombin inhibitors |
US5792779A (en) * | 1997-02-19 | 1998-08-11 | Merck & Co., Inc. | Pyridinone thrombin inhibitors |
US6011038A (en) * | 1997-09-05 | 2000-01-04 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
US6087373A (en) * | 1997-09-23 | 2000-07-11 | Merck & Co., Inc. | Thrombin inhibitors |
US6133297A (en) * | 1997-09-30 | 2000-10-17 | Merck & Co., Inc. | Thrombin inhibitors |
WO1999045928A1 (fr) * | 1998-03-11 | 1999-09-16 | Welfide Corporation | INHIBITEURS DE PRODUCTION D'ANTICORPS IgE ET INHIBITEURS DE MALADIES AUTO-IMMUNES |
US6147078A (en) * | 1998-05-19 | 2000-11-14 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
CA2343109A1 (en) * | 1998-09-28 | 2000-04-06 | Merck & Co., Inc. | Thrombin inhibitors |
WO2000026210A1 (en) | 1998-10-30 | 2000-05-11 | Merck & Co., Inc. | Thrombin inhibitors |
JP2002528543A (ja) | 1998-10-30 | 2002-09-03 | メルク エンド カムパニー インコーポレーテッド | トロンビン阻害剤 |
US6239132B1 (en) | 1999-04-23 | 2001-05-29 | Merck & Co., Inc. | Thrombin inhibitors |
JP2003501389A (ja) | 1999-06-04 | 2003-01-14 | メルク エンド カムパニー インコーポレーテッド | トロンビン阻害物質 |
UA58636C2 (uk) | 1999-06-04 | 2003-08-15 | Мерк Енд Ко., Інк. | Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням |
WO2001038323A1 (en) | 1999-11-23 | 2001-05-31 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
WO2001070229A1 (en) | 2000-03-23 | 2001-09-27 | Merck & Co., Inc. | Thrombin inhibitors |
TW200500341A (en) * | 2002-11-12 | 2005-01-01 | Astrazeneca Ab | Novel compounds |
PE20050159A1 (es) * | 2003-05-27 | 2005-04-19 | Vertex Pharma | Derivados de acido 3-[2-(3-amino-2-oxo-2h-piridin-1-il)-acetilamino]-4-oxo-pentanoico como inhibidores de caspasa |
SE0302487D0 (sv) * | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
WO2006057961A1 (en) | 2004-11-24 | 2006-06-01 | Vertex Pharmaceuticals Incorporated | 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
US8350043B2 (en) | 2005-06-07 | 2013-01-08 | Pharmacopeia, Inc. | Azinone and diazinone V3 inhibitors for depression and stress disorders |
BRPI0611922A2 (pt) * | 2005-06-08 | 2010-10-05 | Novartis Ag | compostos orgánicos |
CN110950807B (zh) * | 2018-09-26 | 2023-03-03 | 中国科学院上海药物研究所 | 联芳基类化合物、其制备方法、药物组合物及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4474778A (en) * | 1983-11-09 | 1984-10-02 | E. R. Squibb & Sons, Inc. | Lactam containing compounds, their pharmaceutical compositions and method of use |
GB8600263D0 (en) * | 1985-01-22 | 1986-02-12 | Ici America Inc | Peptide derivatives |
-
1992
- 1992-04-01 GB GB929207145A patent/GB9207145D0/en active Pending
- 1992-04-10 FI FI921598A patent/FI921598A/fi not_active Application Discontinuation
- 1992-04-10 NZ NZ242322A patent/NZ242322A/en unknown
- 1992-04-10 IL IL101555A patent/IL101555A0/xx unknown
- 1992-04-10 NO NO92921451A patent/NO921451L/no unknown
- 1992-04-10 AU AU14827/92A patent/AU660664B2/en not_active Ceased
- 1992-04-10 HU HU9201225A patent/HUT66541A/hu unknown
- 1992-04-10 IE IE115992A patent/IE921159A1/en unknown
- 1992-04-10 KR KR1019920006072A patent/KR920019750A/ko not_active Application Discontinuation
- 1992-04-10 CA CA002065794A patent/CA2065794A1/en not_active Abandoned
- 1992-04-15 DE DE69213537T patent/DE69213537T2/de not_active Expired - Fee Related
- 1992-04-15 EP EP92303358A patent/EP0509769B1/de not_active Expired - Lifetime
- 1992-04-16 CS CS921176A patent/CS117692A3/cs unknown
- 1992-04-18 JP JP4143140A patent/JPH0656785A/ja active Pending
- 1992-04-29 TW TW081103383A patent/TW262475B/zh active
Also Published As
Publication number | Publication date |
---|---|
EP0509769A2 (de) | 1992-10-21 |
DE69213537T2 (de) | 1997-02-20 |
FI921598A0 (fi) | 1992-04-10 |
KR920019750A (ko) | 1992-11-19 |
AU1482792A (en) | 1992-10-22 |
CA2065794A1 (en) | 1992-10-19 |
EP0509769B1 (de) | 1996-09-11 |
IE921159A1 (en) | 1992-10-21 |
GB9207145D0 (en) | 1992-05-13 |
HU9201225D0 (en) | 1992-07-28 |
HUT66541A (en) | 1994-12-28 |
IL101555A0 (en) | 1992-12-30 |
JPH0656785A (ja) | 1994-03-01 |
FI921598A (fi) | 1992-10-19 |
NZ242322A (en) | 1994-12-22 |
NO921451D0 (no) | 1992-04-10 |
DE69213537D1 (de) | 1996-10-17 |
EP0509769A3 (en) | 1993-09-01 |
CS117692A3 (en) | 1992-11-18 |
AU660664B2 (en) | 1995-07-06 |
TW262475B (en) | 1995-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO921451L (no) | Heterocykliske amider | |
DK34793A (da) | Vandoploeseligt, farmaceutisk acceptabelt salt af et monoacylderivat af rapamycin, fremgangsmaade til dets fremstilling og injicerbart, farmaceutisk praeparat indeholdende det | |
ES8605511A1 (es) | Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos. | |
ES8101564A1 (es) | Un procedimiento para la preparacion de nuevos derivados he-terociclicos | |
ES8402268A1 (es) | Un procedimiento para la preparacion de un derivado del indol. | |
ES462006A1 (es) | Procedimiento para la obtencion de nuevas feniletilaminas. | |
MY103905A (en) | Aminoalkoxyphenyl derivatives, process of preparation and compositions containing the same. | |
GR76356B (de) | ||
GB1298112A (en) | Phenyl acetyl guanidine derivatives | |
DK0579059T3 (da) | Pyridazinonderivater og fremgangsmåder til fremstilling af samme | |
DK23089A (da) | Thioformamidderivater og deres anvendelse | |
ES8801205A1 (es) | Un procedimiento para la produccion de una isatina y una sal de la misma | |
IL66384A (en) | Indolin-2-one(3,4-dihydroquinol-2-one or quinol-2-one)-oxyalkylsulphimines and salts thereof,their preparation and pharmaceutical compositions containing them | |
HUT43568A (en) | Process for preparing novel 2-pyridiyl-acetic acid derivatives and pharmaceutics comprising the same | |
GB1142508A (en) | Pyrrole derivatives | |
DK48188A (da) | Ergolinyl-heterocycliske forbindelser og fremgangsmaade til fremstilling deraf | |
GB1292094A (en) | A phenylglycine derivative | |
ATE44741T1 (de) | 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere. | |
ES324379A1 (es) | Un metodo para la preparacion de derivados basicos de ftalanos e isocromanos. |